Site specific protein modifications
A protein and target protein technology, applied in the field of amino functional groups, can solve problems such as the difficulty of selective derivatization of proteins/peptides
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0091] Various embodiments of the invention are described herein. It will be appreciated that features specified in each embodiment may be combined with other specified features to provide other embodiments.
[0092] In embodiment 1, the present invention relates to a method for modifying a target protein or target peptide at an amino functional group of an N-terminal amino acid, said method comprising the steps of:
[0093] c. modifying the target protein or target peptide such that the resulting protein or peptide contains a histidine amino acid at a position adjacent to the N-terminal amino acid;
[0094] d. Contacting a protein or peptide containing a histidine amino acid at a position adjacent to the N-terminal amino acid with an acylation compound at a pH below 6 to form a modified protein or peptide.
[0095] In embodiment 2, the invention relates to a method according to embodiment 1, wherein said protein or peptide containing a histidine amino acid at a position adja...
Embodiment approach 16
[0124] Embodiment 16, the invention relates to the method according to embodiment 14, wherein R 1 is the fatty acid (FA) moiety. Examples of fatty acids are fatty acids with at least one carboxylic acid (e.g. 1, 2, 3 or 4 CO 2 H) C substituted and optionally further substituted with hydroxyl 6-70 Alkyl, C 6-70 Alkenyl, C 6-70 Alkynyl chain. The fatty acid (FA) is preferably via the linker L 1 Conjugate to target protein or target peptide. In embodiment 16A, the invention relates to a method according to embodiment 16, wherein R 1 Acids selected from:
[0125]
[0126] R 2 is CO 2 H, H;
[0127] R 3 , R 4 and R 5 independently of each other are H, OH, CO 2 H, -CH=CH 2 or –C = CH;
[0128] Ak 1 is branched C 6 -C 30 alkylene;
[0129] q, r and p are independently of each other an integer between 6 and 30; and wherein the junction is CO 2 H functional group; or any one of amides, esters, or pharmaceutically acceptable salts thereof.
[0130] In embodimen...
Embodiment 1
[0364] Example 1: Step b of the present invention using AHNGDLKF-NH2 and sulfo-NHS-LC biotin as acylating agents.
[0365] LCMS product retention time: 1.81 min; measured value: [M+H] + =1239.63; calculated value: [M+H] + =1239.6200).
[0366] Plotted data (using MALDI LIFT method): Biotin + Alanine: Measured value: [M+H] + = about 411; Calculated: [M+H]+ = 411.21). Biotin+AH: measured value: [M+H] + =548.27; Calculated value: [M+H] + = 548.27). No individual alanine mass was detected.
PUM
| Property | Measurement | Unit |
|---|---|---|
| molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


